BioGaia AB (publ) 0GTN.IL Stock
BioGaia AB (publ) Price Chart
BioGaia AB (publ) 0GTN.IL Financial and Trading Overview
| BioGaia AB (publ) stock price | 115.9 SEK |
| Previous Close | 111.69 SEK |
| Open | 0 SEK |
| Bid | 0 SEK x 0 |
| Ask | 0 SEK x 0 |
| Day's Range | 111.69 - 111.69 SEK |
| 52 Week Range | 69 - 113.3 SEK |
| Volume | 23.32K SEK |
| Avg. Volume | 18.38K SEK |
| Market Cap | 11.26B SEK |
| Beta (5Y Monthly) | 0.693103 |
| PE Ratio (TTM) | 5.8413625 |
| EPS (TTM) | 4.12 SEK |
| Forward Dividend & Yield | 1.45 (1.33%) |
| Ex-Dividend Date | May 9, 2023 |
| 1y Target Est | N/A |
0GTN.IL Valuation Measures
| Enterprise Value | 9.57B SEK |
| Trailing P/E | 5.8413625 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.492869 |
| Price/Book (mrq) | 5.404377 |
| Enterprise Value/Revenue | 8.068 |
| Enterprise Value/EBITDA | 23.915 |
Trading Information
BioGaia AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.693103 |
| 52-Week Change | 18.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 113.3 SEK |
| 52 Week Low | 69 SEK |
| 50-Day Moving Average | 100.43 SEK |
| 200-Day Moving Average | 91.5 SEK |
0GTN.IL Share Statistics
| Avg. Volume (3 month) | 18.38K SEK |
| Avg. Daily Volume (10-Days) | 15.54K SEK |
| Shares Outstanding | 97.28M |
| Float | 80.84M |
| Short Ratio | N/A |
| % Held by Insiders | 3.59% |
| % Held by Institutions | 52.69% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.45 |
| Trailing Annual Dividend Yield | 1.29% |
| 5 Year Average Dividend Yield | 108.00% |
| Payout Ratio | 0.038399998 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 34.86% |
| Operating Margin (ttm) | 32.47% |
| Gross Margin | 72.70% |
| EBITDA Margin | 33.73% |
Management Effectiveness
| Return on Assets (ttm) | 10.56% |
| Return on Equity (ttm) | 20.44% |
Income Statement
| Revenue (ttm) | 1.19B SEK |
| Revenue Per Share (ttm) | 11.74 SEK |
| Quarterly Revenue Growth (yoy) | 28.89% |
| Gross Profit (ttm) | 801.93M SEK |
| EBITDA | 400.07M SEK |
| Net Income Avi to Common (ttm) | 413.42M SEK |
| Diluted EPS (ttm) | 19.12 |
| Quarterly Earnings Growth (yoy) | 52.00% |
Balance Sheet
| Total Cash (mrq) | 1.58B SEK |
| Total Cash Per Share (mrq) | 15.65 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 10.321 |
| Book Value Per Share (mrq) | 20.666 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 324.31M SEK |
| Levered Free Cash Flow (ttm) | 217.33M SEK |
Profile of BioGaia AB (publ)
| Country | United Kingdom |
| State | N/A |
| City | Stockholm |
| Address | Kungsbroplan 3 |
| ZIP | 112 27 |
| Phone | 46 8 55 52 93 00 |
| Website | https://www.biogaia.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 211 |
BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pylorithe gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. The company sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
Q&A For BioGaia AB (publ) Stock
What is a current 0GTN.IL stock price?
BioGaia AB (publ) 0GTN.IL stock price today per share is 115.9 SEK.
How to purchase BioGaia AB (publ) stock?
You can buy 0GTN.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioGaia AB (publ)?
The stock symbol or ticker of BioGaia AB (publ) is 0GTN.IL.
Which industry does the BioGaia AB (publ) company belong to?
The BioGaia AB (publ) industry is Drug Manufacturers-Specialty & Generic.
How many shares does BioGaia AB (publ) have in circulation?
The max supply of BioGaia AB (publ) shares is 103.69M.
What is BioGaia AB (publ) Price to Earnings Ratio (PE Ratio)?
BioGaia AB (publ) PE Ratio is 28.13107000 now.
What was BioGaia AB (publ) earnings per share over the trailing 12 months (TTM)?
BioGaia AB (publ) EPS is 4.12 SEK over the trailing 12 months.
Which sector does the BioGaia AB (publ) company belong to?
The BioGaia AB (publ) sector is Healthcare.